Clinical trial

Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP

NCT03978559

Study summary

ClinicalTrials.gov

Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCP

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record caspofungin Normalized identity: caspofungin View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention TMP/SMZ(trimethoprim/sulfisoxazole) Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Methylprednisolone Normalized identity: methylprednisolone View linked drug · Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-08-14

PhasePHASE4

Conditions

Pneumocystis Pneumoniaverified · MONDO: pneumocystosis

Interventions

caspofunginDRUG · verified · RxNorm: caspofungin

TMP/SMZ(trimethoprim/sulfisoxazole)DRUG

MethylprednisoloneDRUG · verified · RxNorm: methylprednisolone

Sponsors & collaborators

Bin Dulead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03978559 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.